DIANA SEBASTIAN: Open Payments
NPI 1316402555 · LEWISVILLE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,169 in 53 payments from 18 companies in 2025. Trend: 2023 $40 · 2024 $214 · 2025 $1,169
Food & beverage: $1,169
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 11 | $219 |
| Tandem Diabetes Care, Inc. | 7 | $194 |
| Radius Health, Inc. | 3 | $143 |
| Dexcom, Inc. | 5 | $113 |
| Corcept Therapeutics | 5 | $107 |
| BETA BIONICS, INC. | 4 | $62 |
| Xeris Pharmaceuticals, Inc. | 3 | $61 |
| Sequel Med Tech, LLC | 2 | $41 |
| Lilly USA, LLC | 2 | $35 |
| Antares Pharma, Inc. | 2 | $31 |
Products named: t:slim X2 Insulin Pump with Control-IQ, Ozempic, Tymlos, Dexcom G6 Transmitter, Korlym, iLet Bionic Pancreas, GVOKE HYPOPEN, Wegovy.
Industry payments across TX — which companies pay providers there.
